The largest database of trusted experimental protocols

8 protocols using polysorbate 80

1

Monoclonal Antibody and Enzyme Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A monoclonal antibody (IgG 1 , MW ~145 kDa, pI 9.15, referred to as mAb1) and an enzyme (MW ~59 kDa, pI 7.16) were supplied by F. Hoffmann-La Roche/Genentech. The antibody was formulated at protein concentrations of 10 and 100 mg/mL with 240 mM sucrose in a 20 mM histidine hydrochloride buffer at pH 5.8. The 10 mg/mL and the 100 mg/mL formulation contained 0.004% (w/v) or 0.04% (w/v) polysorbate 20 (Croda, Snaith, UK). The enzyme was formulated at a protein concentration of 2.5 mg/mL with 500 mM arginine phosphate buffer at pH 7.3 and 0.01% (w/v) polysorbate 80 (Croda, Snaith, UK). All formulations were filtered with 0.22 µm polyethersulfone membrane filters (Corning, Corning, NY, USA) prior to filling to nominal fill volumes in vial configurations as summarized in Table 1. All vials were pharmaceutical Type 1 borosilicate glass tubing vials (Schott AG, Mainz, Germany). The 2 cc vials had 13 mm openings, while the 6 cc, 20 cc, and 50 cc vials had 20 mm openings. All vials were partially stoppered with lyophilization stoppers (Daikyo Seiko, Tochigi Prefecture, Japan). The vials were arranged in hexagonal packs in the lyophilizer.
+ Open protocol
+ Expand
2

Δ9THC Nanoformulation Development

Check if the same lab product or an alternative is used in the 5 most similar protocols
Δ9THC (3.2537 g) was added to a beaker. To this 0.625 g of 100% Ethanol (Lot no-007116 , Decon Lab, King of Prussia, PA) was added and sonicated until Δ9THC was dissolved. This was followed by the addition of 7.5 g of GTCC MBAL SG oil (Lot no- 42733, Crodamol, Plainsboro, NJ) and 2.7 g of polysorbate 80 (Lot no-1186606, Croda, Plainsboro, NJ). The mixture was sonicated until dissolved. This is the oil phase. In another beaker, 0.06 g of ascorbic acid (Lot no-181977 Fisher Chemicals, Waltham, MA) was dissolved in 18 g of Milli-Q water. This water was added to the oil phase while stirring using an electric stirrer for about 15 minutes to make it an emulsion. After this, the pH of this solution was set around 7 using a diluted sodium hydroxide solution. This emulsion was passed through the homogenizer (Make-Avestin, Emulsiflex C3) for 3 cycles at 10,000–15,000 psi. The particle size of this formulation was found to be an average of 150 nm. The concentration Δ9THC in the nanoformulation was 8% by weight. The cannabinoid metabolites 11-hydroxy-THC (THC-OH) and tetrahydrocannabinol carboxylic acid (Δ9THC-COOH) were purchased from Cayman Chemicals (Ann Arbor, MI).
+ Open protocol
+ Expand
3

Development of Carbamazepine-Sacha Inchi Oil Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CBZ and sacha inchi oil (SIO) were provided by Tecnoquimicas S.A Pharmaceutical Company (Cali, Valle del Cauca, Colombia) and Nutresacha SA (Santander de Quilichao, Cauca, Colombia), respectively. Sorbitan oleate (SpanTM 80, hydrophilic-lipophilic balance (HLB) = 4.3) and Polysorbate 80 (TweenTM 80, HLB = 15) were purchased from Croda (Snaith, UK). Methyl-paraben and propyl-paraben were acquired from Sigma-Aldrich (St. Louis, MO, USA). Water Type II (ultrapure water) was obtained via a Millipore Elix Essential purification system (Merck KGaA, Darmstadt, Germany), while the water employed for high-performance liquid chromatography (HPLC) was purified using a Sartorius Arium-Pro (Sartorius AG, Gotinga, Germany). All solvents were of analytical reagent grade.
+ Open protocol
+ Expand
4

EphA2 Expression and DS-8895a Conjugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
EphA2 expression was assessed by staining 1 • 10 6 MDA-MB-231 cells with a 10 mg/mL dose of humanized DS-8895a, followed by phycoerythrin antihuman secondary antibody. Flow cytometric analysis was performed using Guava flow cytometry (Guava easyCyte 8HT flow cytometer, model 0500-4008; Guava Technologies).
Conjugation of Deferoxamine-p-SCN to DS-8895a for Radiolabeling DS-8895a was obtained from Daiichi Sankyo Co., Ltd., and was chelated either with the bifunctional metal ion chelator CHX-A$-DTPA (Macrocyclics Inc.) at a 5.0-fold molar excess or with deferoxaminep-SCN (Df-Bz-NCS; Macrocyclics Inc.) at a 3.0-fold molar excess. Two-milligram aliquots of the conjugates in 50 mM sodium acetate buffer (BDH/VWR Chemicals), pH 5.6, containing 5% w/v sorbitol (BDH/VWR Chemicals) and 0.01% w/v polysorbate 80 (Croda) were stored at 280°C until required.
+ Open protocol
+ Expand
5

Formulation and Evaluation of a Gastro-Resistant Drug Delivery System

Check if the same lab product or an alternative is used in the 5 most similar protocols
EMP was a gift from Lee Pharma Limited (Hyderabad, India). D-mannitol was provided by Roquette (Lesterem, Singapore). Low-substituted hydroxypropyl cellulose (L-HPC) and hypromellose (HPMC) 2910 were purchased from Shin-Etsu (Tokyo, Japan). Croscarmellose sodium (CMC-Na) was obtained from DuPont Nutrition (Newark, DE, USA). HPC L-type (HPC-L) was supplied by Nippon Soda Co., Ltd. (Tokyo, Japan). Sodium stearyl fumarate (SSF) was purchased from JRS Pharma (Polanco, Spain). Talc was purchased from Merck (Darmstadt, Germany). Triethyl citrate (TEC) was purchased from MORIMURA Bros., INC. (Tokyo, Japan). Glycerol monostearate (GMS) was obtained from Gattefosse (Saint-Priest, France). Polysorbate 80 was purchased from CRODA (Seraya, Singapore). Iron oxide red was obtained from VENATOR (Turin, Italy). ELD-55, ES-100, and EL-100 were obtained from Evonik Industries (Darmstadt, Germany). Hard capsules (HPMC) were obtained from SUHEUNG Co., Ltd. (Cheongju, Korea). A commercial product (Nexium® tablet; 40 mg) was purchased from AstraZeneca Korea Co. (Seoul, Korea). All other reagents were of reagent grade and used without further purification.
+ Open protocol
+ Expand
6

Polysorbate 80 Characterization and Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
polysorbate 80 NF was purchased from Spectrum Biochemical. Super refined polysorbate 80 with C18:1 fatty acid content ≥98% designated as “high oleic acid PS80 (PS80 HOA)” throughout this manuscript, was kindly provided by Croda Inc. rhG-CSF was purchased as filgrastim reference standard from USP and rituximab from Genentech, Inc. Porcine liver esterase was purchased from Sigma. Mouse phospholipase B-like 2 (PLBD2) was purchased from Biorbyt. All chemicals were purchased from Sigma unless otherwise specified.
+ Open protocol
+ Expand
7

Polysorbate 80 Characterization and EPR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Different quality grades and batches of polysorbate 80 were purchased from Croda (International Plc. Snaith, UK): (i) high purity (HP), (ii) super-refined (SR), and (iii) all-oleate (AO) as well as from Nanjing Well (Nanjing, China): (iv) china grade (CG) (see Table S1). DMPO (5,5-Dimethyl-1-Pyrroline-N-Oxide) was purchased from Dojindo Molecular Technologies (Rockville, US), Tempol (4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) in a solid crystalline form from Sigma-Aldrich Chemie GmbH (Taufkirchen, Germany). Glass capillaries (Blaubrand) and Critoseal for the EPR experiments were obtained from Brand GmbH & Co. KG (Wertheim, Germany).
+ Open protocol
+ Expand
8

Lyophilized IgG1 mAb Protein Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lyophilized IgG1 mAb samples prepared at 0.6% and 6.8% moisture content, and their corresponding matching placebos without protein, were supplied in stoppered 20 mL glass vials by Human Genome Sciences (currently GlaxoSmithKline). Upon reconstitution with 5 mL of deionized water from Water Pro PS Station (Labconco, Kansas City, MO), the target concentration was approximately 30 mg/mL protein, in a formulation consisting of 0.08 mg/mL citric acid monohydrate (Avantor Performance Materials, JT Baker 0115, Center Valley, PA), 1.6 mg/mL sodium citrate dihydrate (Avantor Performance Materials, JT Baker 3647), 11 mg/mL glycine (Avantor Performance Materials, JT Baker 0581), 3 mg/mL sucrose (Avantor Performance Materials, JT Baker 4005), and 0.12 mg/mL polysorbate-80 (Croda International, SR48833, England) at pH 6.5. Lyophilized samples were stored at 4 °C unless otherwise indicated. The IgG1 mAb has a pI of ∼8.4 and protein concentrations were determined by UV spectroscopy at 280 nm with an extinction coefficient of ε 0.1% =1.58 (g/100mL)-1 cm-1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!